Tag: congress

21 Sep 2017
img

During recent testimony before the Senate Health, Education, Labor and Pension Committee hearing on Stabilizing the Affordable Care Act Marketplace, AARP became the largest consumer organization to publicly support the prescription drug policy solutions reflected in Prescription Justice’s policy platform. AARP supports commonsense policy reforms to allow Medicare to negotiate drug prices, end pay-for-delay deals that delay entry of generic drugs into the marketplace, and increase access to lower cost medications through safe prescription drug importation. As part of a larger set of priorities for protecting and strengthening the healthcare system, AARP boldly declared that any changes to the healthcare law must include solutions to address rising prescription drug costs. (more…)

21 Jul 2017
img

The Prescription Justice coalition letter from last month, signed by a growing number of consumer, health and social justice organizations, supports S. 469/ H.R. 1245, The Affordable and Safe Prescription Drug Importation Act of 2017, introduced by Senator Bernie Sanders, I-VT and Representative Elijah Cummings, D-MD. If enacted, this bill would allow individuals, pharmacies and wholesalers to import FDA-approved medications from Canada, and then, after two years, from other countries with equally rigorous systems for regulating the safety and efficacy of pharmaceuticals.

Prescription Justice also supports S. 64 / H.R. 1480, The Safe and Affordable Drugs from Canada Act of 2017, introduced by Senator John McCain, R-AZ and Representative Chellie Pingree, D-ME. This bill would allow for the personal importation of safe and affordable drugs from approved pharmacies in Canada. Prescription medications imported under this bill would be the same dosage, form, and potency as drugs in the U.S., but at a significant savings to Americans.

(more…)

08 Jun 2017
img

Prescription Justice is proud to announce that we have sent a letter to the U.S. Congress, signed by non-profit organizations dedicated to American consumers, patients and families who struggle with the high cost of medication. The letter specifically calls for the passage of the Affordable and Safe Prescription Drug Importation Act of 2017, introduced by Senators Cory Booker, Bob Casey, and Bernie Sanders. The Act would expressly allow importation of lower cost medications from Canada, and, after two years, other countries with strong pharmaceutical regulations. Uniquely, the letter also recognizes that Americans already import medication for personal use, often ordering them from international online pharmacies, regardless of the federal restrictions. That practice can be safe but rogue websites are a threat to patient safety.

The Act would require the FDA to register qualified international pharmacies and identify websites that sell FDA-approved medications directly to consumers from licensed pharmacies; create registration requirements with multiple layers of oversight to permit U.S. pharmacies to import wholesale quantities that could be sold at much lower price; and increase penalties for online pharmacies that knowingly sell counterfeit drugs. 

Passing drug importation legislation is just one important step in the right direction to bring an end to the crisis of high drug prices in America. 

Letter to the U.S. House of Representatives in support of safe drug importation

Letter to the U.S. Senate in support of safe drug importation

Groups that signed the letter are listed below:

Alliance for Retired Americans

Center for Medicare Advocacy

CREDO

DailyKos

Economic Policy Institute Policy Center

Justice in Aging

National Nurses United

National Organization for Women

Prescription Justice

RxRights

Social Security Works